The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials (Q40396624)
Jump to navigation
Jump to search
scientific article published on January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials |
scientific article published on January 1994 |
Statements
1 reference
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials (English)
1 reference
Bostwick DG
1 reference
Burke HB
1 reference
Wheeler TM
1 reference
Chung LW
1 reference
Bookstein R
1 reference
Pretlow TG
1 reference
Nagle RB
1 reference
Montironi R
1 reference
Lieber MM
1 reference
Veltri RW
1 reference
1 January 1994
1 reference
1 reference
19
1 reference
283-289
1 reference
Identifiers
1 reference